The company is showcasing new development solutions and advanced digital technologies including its new OSD Express and Steriles Express solutions for drug development.
News|Articles|January 1, 2003
- Pharmaceutical Technology-01-01-2003
- Volume 27
- Issue 1
Outsourcing Outlook
Author(s)Jim Miller
Developments in 2002 such as acquisitions, excess manufacturing capacity, and less funding for biotechnology will continue to affect the industry long into the new year.
Advertisement
Articles in this issue
almost 24 years ago
Pharmaceutical Pricing and Innovation Key Issues for 2003almost 24 years ago
Procedures: Improving Their Qualityalmost 24 years ago
Drug-Carrier Screening on a Chipalmost 24 years ago
Pack EXPO International 2002 Proves Worth the Tripalmost 24 years ago
Analysis of the Indian Pharmaceutical IndustryAdvertisement
Related to this article
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Germany’s Medical Biotechnology Sector is Flourishing
2
Formulation Strategies for Next-Generation Multiagonists
3
MASH and Cardiomyopathy Targets: Why AstraZeneca Chose insitro’s AI
4
First-in-Human Trial Speed: Why FDA Trails China
5